Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Biosimilars V 2.0

Biosimilars: SOP for Metabolite Monitoring (Glucose, Lactate, Ammonia) in Bioreactor Operations – V 2.0

Posted on By

To establish the procedure for monitoring key metabolites such as glucose, lactate, and ammonia in bioreactor operations for biosimilar manufacturing, ensuring optimal cell growth and product yield.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Online Sensor Calibration in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for online calibration of bioreactor sensors including pH, Dissolved Oxygen (DO), and temperature sensors to ensure accuracy and regulatory compliance during biosimilar production.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for pCO₂ and pO₂ Monitoring in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for monitoring partial pressure of carbon dioxide (pCO₂) and oxygen (pO₂) during bioreactor operations for biosimilar production, using inline sensors and off-line validation to ensure cell culture health and productivity.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for In-Process pH Drift Correction in Bioreactor Operations – V 2.0

Posted on By

To provide standardized guidelines for detecting and correcting in-process pH drift during bioreactor operations in biosimilar manufacturing to maintain culture conditions and ensure product consistency.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Cell Viability Testing (Trypan Blue, Flow Cytometry) in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for assessing cell viability in bioreactor cultures using the Trypan Blue exclusion method and flow cytometry, ensuring accurate evaluation of culture health during biosimilar production.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Harvest Decision and Timing in Bioreactor Operations – V 2.0

Posted on By

To establish a standardized procedure for determining the optimal time to harvest bioreactor cultures during biosimilar production, based on defined critical process parameters and quality attributes.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Centrifugation of Harvested Broth in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for centrifuging harvested culture broth from bioreactor operations during biosimilar manufacturing, with the aim of separating biomass and collecting clarified supernatant for downstream processing.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations – V 2.0

Posted on By

To describe the standardized procedure for primary clarification of harvested cell culture broth using depth filtration systems to remove cell debris and insoluble impurities prior to downstream purification in biosimilar manufacturing.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Tangential Flow Filtration (TFF) in Bioreactor Operations – V 2.0

Posted on By

To outline the procedure for executing Tangential Flow Filtration (TFF) to concentrate and perform buffer exchange on clarified cell culture supernatant as part of upstream/downstream transition in biosimilar production.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Hold Time Studies in Harvest Tanks in Bioreactor Operations – V 2.0

Posted on By

To establish a systematic approach for conducting hold time studies in harvest tanks used during biosimilar production. This ensures harvested material maintains stability, sterility, and identity during defined storage periods prior to downstream processing.
Click to read the full article.

Biosimilars V 2.0

Posts pagination

Previous 1 … 8 9 10 … 20 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme